Skip to main content

Diabetes and Metabolism

The Diabetes and Metabolism Research Group is search is lead by Dr. Rafael Simó (Hirsch index:54), Head of the Endocrinology Department, Professor of Medicine & Endocrinology at UAB and current President of the European Association for the Study of Diabetes-Eye Complications. The group consists of 7 senior clinical investigators, 4 basic post-doctoral researchers, 4 pre-doc researchers, 3 laboratory technicians and one coordinator of clinical assays.  

The group belongs to “CIBER” of Diabetes and Associated Metabolic Diseases (CIBERDEM. ISCIII) and has been recognized as consolidated group by the Generalitat de Catalunya (AQU/AGAUR).

Since 2014 this group has been qualified as outstanding in the evaluations performed by the ANEP, CIBERDEM and the external Scientific Advisory Board of VHIR. 

The main lines of research are:

  • Complications of diabetes (in particular diabetic retinopathy)
  • Obesity and its co-morbidities
  • Type 2 diabetes and cognitive impairment
  • Thyroid diseases
  • Hospital Nutrition. 

Team

Maria Llorian Salvador

Maria Llorian Salvador

Main researcher
Diabetes and Metabolism
Read more
Mercè Abad Martín

Mercè Abad Martín

Research technician
Diabetes and Metabolism
Read more
Monica Sanchez Bartres

Monica Sanchez Bartres

Main researcher
Diabetes and Metabolism
Read more
Olga Simó Servat

Olga Simó Servat

Main researcher
Diabetes and Metabolism
Read more
Patricia Bogdanov Baruj

Patricia Bogdanov Baruj

Postdoctoral researcher
Diabetes and Metabolism
Read more
Rafael Simó Canonge

Rafael Simó Canonge

Head of group
Diabetes and Metabolism
Read more
Maria Llorian Salvador

Maria Llorian Salvador

Main researcher
Diabetes and Metabolism
Read more
Mercè Abad Martín

Mercè Abad Martín

Research technician
Diabetes and Metabolism
Read more
Monica Sanchez Bartres

Monica Sanchez Bartres

Main researcher
Diabetes and Metabolism
Read more
Olga Simó Servat

Olga Simó Servat

Main researcher
Diabetes and Metabolism
Read more
Patricia Bogdanov Baruj

Patricia Bogdanov Baruj

Postdoctoral researcher
Diabetes and Metabolism
Read more
Rafael Simó Canonge

Rafael Simó Canonge

Head of group
Diabetes and Metabolism
Read more

Projects

Impacto de la cirugía bariátrica en la hemodinámica portal en pacientes con obesidad mórbida y NAFLD. Estudio HEYMDAL.

IP: Ramón Vilallonga Puy
Collaborators: Carlos Petrola Chacón, Mercedes Pérez Lafuente, Elisa Merino Peña, Nuria Roson Gradaille, Laura Puente Ramo, Marta Comas Martinez, Alba Rojano Toimil, Arturo Cirera De Tudela, Alba Maria Jiménez Masip
Funding agency: Instituto de Salud Carlos III
Funding: 171820
Reference: PI22/00880
Duration: 01/01/2023 - 31/12/2026

H2O Health Outcomes Observatory

IP: Yolima Cossio Gil
Collaborators: Alba García Zarzoso, Rafael Simó Canonge, Maria Carmen Baraldés Vallverdú, Joan Carles Peiró Ruiz, Monica Sanchez Bartres, Xavier Serra Ruiz, Marta Ferri Peradalta, Olga Simó Servat, Elena Céspedes Martínez, Ernesto Alejand Lastiri González
Funding agency: The Innovative Medicines Initiative
Funding: 1097257.5
Reference: H2O_IMI2-2020
Duration: 01/10/2020 - 30/04/2026

Estudio de seguridad y eficacia de la sitagliptina en colirio para el tratamiento de los estadios iniciales de retinopatía diabética.

IP: Rafael Simó Canonge
Collaborators: José García Arumí, Cristina Hernández Pascual, Cristina Pérez Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 573650
Reference: ICI20/00129
Duration: 01/01/2021 - 31/10/2026

Desentrañando las vías protectoras de los SGLT2i y GLP-1RA en la enfermedad renal diabética: papel de las proteínas adaptadoras MAP17 y D-AKAP-2 en ratones db/db y organoides renales humanos.

IP: Maria Jose Soler Romeo
Collaborators: Alejandra Gabaldon Dominguez, Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Irene Martinez Diaz, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá
Funding agency: Instituto de Salud Carlos III
Funding: 122210
Reference: PI21/01292
Duration: 01/01/2022 - 30/06/2026

Blog

News

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.